News about Global Pharma

Acepodia Signs Strategic Clinical Partnership with Pfizer for Autoimmune Diseases

Under this new agreement, Pfizer Ignite will provide strategic guidance and resources to Acepodia as the company develops its cell therapies for oncology and autoimmune diseases.

Global Pharma | 04/09/2024 | By Aishwarya |  373

Innovent Secures Fast Track Designation from FDA for IBI363

Innovent Biologics has announced that the US Food and Drug Administration (FDA) has granted Fast Track Designation to its PD-1/IL-2α Bispecific Antibody Fusion Protein for the treatment of unresectable locally advanced or metastatic melanoma.

Global Pharma | 04/09/2024 | By Aishwarya |  750

Gerresheimer to Showcase its Silicone Oil-Free Syringe Systems at CPHI Worldwide 2024

The new syringe systems underline Gerresheimer’s expertise as a system and solution provider for highly sensitive innovative drugs.

Global Pharma | 03/09/2024 | By Aishwarya |  882

India Witnesses Increase in Sales of Unapproved Psychotropic FDCs, Reveals Study

The study, titled 'Sales and Regulatory Status of Fixed Dose Combination Psychotropic Drugs in India: A Retrospective Longitudinal Study,' was published in the Journal of Pharmaceutical Policy and Practice.

Global Pharma | 02/09/2024 | By Aishwarya |  491

Akums Drugs Appoints Amrut Medhekar as New CDMO CEO

Akums Drugs and Pharmaceuticals Ltd. has announced the appointment of Amrut Medhekar as Chief Executive Officer of its CDMO business, approved by the company’s Board of Directors in a recent meeting.

Global Pharma | 02/09/2024 | By Aishwarya |  852

Sanyou Bio Rolls Out Comprehensive Monkeypox Product Line

Developed using Sanyou Bio's proprietary 'over-trillion innovative antibody discovery' platform, the monoclonal antibodies span multiple species, including fully human, nano, and mouse antibodies.

Global Pharma | 31/08/2024 | By Aishwarya |  583

Lupin Unveils Doxorubicin Hydrochloride Liposome Injection in US

Lupin has introduced Doxorubicin Hydrochloride Liposome Injection 20 mg/10 mL (2 mg/mL) and 50 mg/25 mL (2 mg/mL) Single-Dose Vials in the United States.

Global Pharma | 31/08/2024 | By Aishwarya |  832

Flagship Pioneering and Quotient Therapeutics Signs Deal with Pfizer

Pioneering Medicines, Flagship’s in-house drug discovery and development unit, is responsible for leading the strategic partnership with Pfizer, including driving the exploration process to rapidly surface potential drug development programs built on Flagship’s diverse bioplatforms and modalities.

Global Pharma | 29/08/2024 | By Aishwarya |  361

Insud Pharma Completes Acquisition of Agile Therapeutics

Insud Pharma operates throughout the value chain of the pharmaceutical industry, offering specialized knowledge in scientific research, development, manufacturing, sale and marketing of a wide range of active pharmaceutical ingredients (APIs).

Global Pharma | 28/08/2024 | By Aishwarya |  1165

Indica Labs and Paige to Expand Integrated AI for Anatomic Pathology Labs

Indica Labs has signed a non-exclusive partnership with Paige, aimed at integrating Paige’s Diagnostic AI models into Indica’s robust Anatomic Pathology workflow management software, HALO AP.

Global Pharma | 28/08/2024 | By Aishwarya |  695